Insulin and type 1 diabetes: immune connections

被引:29
|
作者
Culina, Sloboda [1 ,2 ]
Brezar, Vedran [1 ,2 ]
Mallone, Roberto [1 ,2 ,3 ]
机构
[1] Hop St Vincent de Paul, INSERM, U986, DeAR Lab Avenir, F-75674 Paris 14, France
[2] Paris Descartes Univ, Fac Med, Paris, France
[3] Hop Hotel Dieu, AP HP, Serv Diabetol, Paris, France
关键词
BETA-CELL FUNCTION; ANTIBODY STANDARDIZATION PROGRAM; THYMIC EPITHELIAL-CELLS; ALTERED-PEPTIDE LIGAND; AUTOREACTIVE T-CELLS; ORAL INSULIN; NOD MICE; 1ST-DEGREE RELATIVES; GENE-EXPRESSION; DENDRITIC CELLS;
D O I
10.1530/EJE-12-0693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin is the hormone produced by pancreatic beta-cells, with a central role in carbohydrate and fat metabolism. Together with its precursors preproinsulin and proinsulin, insulin is also a key target antigen (Ag) of the autoimmune islet destruction leading to type 1 diabetes. Being recognized by both autoantibodies (aAbs) and autoreactive T cells, insulin plays a triggering role, at least in rodent models, in diabetes pathogenesis. It is expressed not only by beta-cells but also in the thymus, where it plays a major role in central tolerance mechanisms. We will summarize current knowledge concerning insulin, its role in beta-cell autoimmunity as initial target Ag, its recognition by aAbs and autoreactive T cells, and the detection of these immune responses to provide biomarkers for clinical trials employing insulin as an immune modulatory agent. European Journal of Endocrinology 168 R19-R31
引用
收藏
页码:R19 / R31
页数:13
相关论文
共 50 条
  • [41] Treatment of Type 1 Diabetes is Changing - Breakthrough in Immune Intervention?
    Wallner, M.
    Thuemer, L.
    Hummel, M.
    Ziegler, A. G.
    DIABETOLOGIE UND STOFFWECHSEL, 2011, 6 (02) : 98 - 103
  • [42] Restoring Regulatory T Cells in Type 1 Diabetes
    Spence, Allyson
    Tang, Qizhi
    CURRENT DIABETES REPORTS, 2016, 16 (11)
  • [43] Stopping Type 1 Diabetes: Attempts to Prevent or Cure Type 1 Diabetes in Man
    Skyler, Jay S.
    Ricordi, Camillo
    DIABETES, 2011, 60 (01) : 1 - 8
  • [44] Innate immune receptors in type 1 diabetes: the relationship to cell death-associated inflammation
    Kim, Tae Kang
    Lee, Myung-Shik
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2020, 48 (03) : 1213 - 1225
  • [45] Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine
    Roep, Bart O.
    Wheeler, Daniel C. S.
    Peakman, Mark
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (01) : 65 - 74
  • [46] Early Impairment of Insulin Sensitivity, β-Cell Responsiveness, and Insulin Clearance in Youth with Stage 1 Type 1 Diabetes
    Galderisi, Alfonso
    Moran, Antoinette
    Evans-Molina, Carmella
    Martino, Mariangela
    Santoro, Nicola
    Caprio, Sonia
    Cobelli, Claudio
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (09) : 2660 - 2669
  • [47] Replacing insulin with immunotherapy: Time for a paradigm change in Type 1 diabetes
    Tatovic, Danijela
    Dayan, Colin M.
    DIABETIC MEDICINE, 2021, 38 (12)
  • [48] Effect of oral insulin on insulin autoantibody levels in the Diabetes Prevention Trial Type 1 oral insulin study
    J. M. Barker
    K. K. McFann
    T. Orban
    Diabetologia, 2007, 50 : 1603 - 1606
  • [49] Effect of oral insulin on insulin autoantibody levels in the Diabetes Prevention Trial Type 1 oral insulin study
    Barker, J. M.
    McFann, K. K.
    Orban, T.
    DIABETOLOGIA, 2007, 50 (08) : 1603 - 1606
  • [50] Immunotherapy for type 1 diabetes
    Frumento, Davide
    Ben Nasr, Moufida
    El Essawy, Basset
    D'Addio, Francesca
    Zuccotti, Gian Vincenzo
    Fiorina, Paolo
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2017, 40 (08) : 803 - 814